Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 63.07 |
| Open | 63.16 |
| Bid | 61.63 x 3000 |
| Ask | 62.02 x 1000 |
| Day's Range | 61.61 - 63.58 |
| 52 Week Range | 57.17 - 74.12 |
| Volume | |
| Avg. Volume | 6,819,650 |
| Market Cap | 77.32B |
| Beta (5Y Monthly) | 0.33 |
| PE Ratio (TTM) | 18.87 |
| EPS (TTM) | 3.27 |
| Earnings Date | Oct 26, 2022 - Oct 31, 2022 |
| Forward Dividend & Yield | 2.92 (4.73%) |
| Ex-Dividend Date | Sept 14, 2022 |
| 1y Target Est | 71.07 |
- Motley Fool
2 Top Biotech Stocks to Buy for the Long Haul
The healthcare industry is a great place to start. Let's examine two biotechs that seem to be able to do that: Gilead Sciences (NASDAQ: GILD) and CRISPR Therapeutics (NASDAQ: CRSP). Gilead Sciences is a leader in the market for HIV drugs although the company has recently faced some headwinds in this space.
- Simply Wall St.
Gilead Sciences, Inc. (NASDAQ:GILD) is a favorite amongst institutional investors who own 81%
A look at the shareholders of Gilead Sciences, Inc. ( NASDAQ:GILD ) can tell us which group is most powerful. And the...
- ACCESSWIRE
Gilead Sciences: Mother of Three Shares Her CAR T-Cell Therapy Journey: Kelly's Story
Kelly was getting ready to leave on a trip to celebrate her 25th wedding anniversary when she started experiencing pain in her abdomen and discovered a lump on her neck. When the pain progressed to the point where it got worse when she laid down, she asked her husband, an emergency room doctor, what he thought.
© 2022 Yahoo. All rights reserved.
